PROGRAMME

PROGRAMME 2019 

Get ready for two jam-packed days of health tech goodness, from applied AI case studies, to announcements from the tech giants, to nitty-gritty coding workshops, and of course, passionate debate on ethics and AI4good in health.

Subscribe to the Intelligent Health mailing list below to receive the programme updates directly in your inbox!

KEY THEMES 2019

THE FUTURE OF HEALTHCARE Where can AI take us with practical, real-world AI use cases

DEEP DIVE AI TECH TALKS Fundamental breakthroughs using AI which will change lives and reshape healthcare

REGULATORS PERSPECTIVES The evolving narrative on how you regulate a device that uses a self-improving algorithm?

MINISTERS PERSPECTIVE Addressing social and behavioural determinants for health using AI

CLINICIANS AND CMIOs PERSPECTIVE How can technologists convince clinicians and CMIOs that AI works and get them to use it?

CONSUMER EMPOWERMENT How to provide better insight into medical data to help healthcare consumers make more informed health decisions

CHINA How China’s tech giants are delivering smart health services, driven by the internet and AI

AI HEALTH TRANSFORMERS Hear from the CEOs and Founders of the most disruptive health tech companies of tomorrow

AI IN GLOBAL HEALTH The latest in population level application of AI in healthcare and tracking progress made towards the health-related Sustainable Development Goals

GET READY TO BE INSPIRED

How many global health problems can we solve using AI?

How can we disrupt old systems from a reactive model to a predictive and preventative model?

From coding to cancer- how can AI make its mark in healthcare?

How should we govern emerging technologies in healthcare?

How can AI be used to do the legwork and speed up drug discovery?

What are the tech giants and AI startups working on to get deep learning into hospitals, clinics and smartphones?

Where are the opportunities to improve clinical practice and augment the healthcare professional?

How can we use AI to shape the way we handle our future well-being?

Day 1 Day 2

MAIN STAGE

MAIN STAGE

REAL WORLD USE CASES

STREAM 1: Examining the potential to transform care delivery and life science research, challenges faced and lessons learnt

DEEP DIVE TECH TALKS

STREAM 2: Fundamental breakthroughs using AI which will change lives and reshape healthcare

AI HEALTH TRANSFORMERS

STARTUPS STAGE: Hear from the CEOs and the Founders of the most disruptive AI health tech companies of tomorrow

CLINICIANS WORKSHOPS

STREAM 3: AI under the hood: Clinicians Workshops

AI WORKSHOPS

STREAM 4: AI under the hood - clinicians workshops

SPEAKER Q&A STAGE

SPEAKER Q&A STAGE
09:00 09:1509:3009:4510:0010:1510:3010:4511:0011:1511:3011:4512:0012:1512:3012:4513:0013:1513:3013:4514:0014:1514:3014:4515:0015:1515:3015:4516:0016:1516:3016:4517:0017:1517:3017:4518:0018:1518:3018:4519:0019:15
WELCOME09:00
SARAH PORTER | BABITA SHARMA | DR. PATRICE MATCHABA

CEO and Founder

Inspired Minds

|

Television Presenter

BBC

|

Group Head of Global Health and Corporate Responsibility

Novartis

SARAH PORTER

CEO and Founder

Inspired Minds

BABITA SHARMA

Television Presenter

BBC

DR. PATRICE MATCHABA

Group Head of Global Health and Corporate Responsibility

Novartis

WELCOME

Where: Main stage
When: 09:00 - 09:20
HEADLINER: The future of healthcare – where can technology and AI take us? 09:20

HEADLINER: The future of healthcare – where can technology and AI take us?

Where: Main stage
When: 09:20 - 09:45
HEADLINER: Building the next generation of smart health services - how Tencent is improving healthcare in China through WeChat and Shadow Chaser 09:45

HEADLINER: Building the next generation of smart health services - how Tencent is improving healthcare in China through WeChat and Shadow Chaser

Where: Main stage
When: 09:45 - 10:10
HEADLINER: How physicians and CIOs can use AI to filter the signal from the noise for data driven thinking and adoption in hospitals 10:35

HEADLINER: How physicians and CIOs can use AI to filter the signal from the noise for data driven thinking and adoption in hospitals

Where: Main stage
When: 10:35 - 11:00
IN-CONVERSATION: Patients Perspective12:35
DR. NATALIE BANNER | MOSES BRAIMAH

Understanding Patient Data Lead

Wellcome Trust

|

Nasopharyngeal Cancer Survivor & CEO

Pacific Messages

DR. NATALIE BANNER

Understanding Patient Data Lead

Wellcome Trust

MOSES BRAIMAH

Nasopharyngeal Cancer Survivor & CEO

Pacific Messages

IN-CONVERSATION: Patients Perspective

When: 12:35 - 13:00

AI for authentic engagement – the voice of the patients in improving AI driven healthcare

What are the current ideas, expectations and concerns from patients and caregivers?
IN-CONVERSATION: Regulators Perspective 11:30

IN-CONVERSATION: Regulators Perspective

Where: Main stage
When: 11:30 - 11:55

The evolving narrative: FDA approval of AI driven devices - how do you regulate a device that uses a self-improving algorithm?

Having gone through the process of approval with the FDA, what the good? What worked? Where is the gap? What still needs to be done to iron out any difficulties? What’s the evolving, future facing narrative?
PANEL DISCUSSION: Clinicians Perspective11:55
DR. ANN AERTS

Head

Novartis Foundation

DR. ANN AERTS

Head

Novartis Foundation

PANEL DISCUSSION: Clinicians Perspective

When: 11:55 - 12:35

How can technologists convince clinicians and CMIOs that AI works and get them to use it?

  What worked in convincing you to adopt through complicated clinical environments, data, regulation challenges?    
LUNCH & NETWORKING 13:00

LUNCH & NETWORKING

When: 13:00 - 14:00
HEADLINER: The perception and reality of AI in health and care - understand your data, understand what you want from it and understand how AI can help you create the actionable insights you need to drive more personalised and efficient care17:00
MARK O’HERLIHY

Managing Director EMEA

IBM Watson Health

MARK O’HERLIHY

Managing Director EMEA

IBM Watson Health

HEADLINER: The perception and reality of AI in health and care - understand your data, understand what you want from it and understand how AI can help you create the actionable insights you need to drive more personalised and efficient care

When: 17:00 - 17:25
PANEL DISCUSSION: Health data governance – how to create a lean and balanced data governance function to maximize the value of your data to deliver the best possible care17:25
VANESSA CANDEIAS | STEFAN GERMANN

Head, Global Health and Healthcare and Member of the Executive Committee

World Economic Forum

|

CEO

Fondation Botnar

VANESSA CANDEIAS

Head, Global Health and Healthcare and Member of the Executive Committee

World Economic Forum

STEFAN GERMANN

CEO

Fondation Botnar

PANEL DISCUSSION: Health data governance – how to create a lean and balanced data governance function to maximize the value of your data to deliver the best possible care

When: 17:25 - 18:00
CLOSE OF SUMMIT DAY ONE 18:00

CLOSE OF SUMMIT DAY ONE

When: 18:00 - 18:00
NETWORKING DRINKS WITH CARESYNTAX18:10
BJOERN VON SIEMENS | DENNIS KOGAN

Co-Founder

Caresyntax

|

Co-Founder

Caresyntax

BJOERN VON SIEMENS

Co-Founder

Caresyntax

DENNIS KOGAN

Co-Founder

Caresyntax

NETWORKING DRINKS WITH CARESYNTAX

When: 18:10 - 19:10
HEADLINER: Novartis 10:10

HEADLINER: Novartis

When: 10:10 - 10:35
REFRESHMENTS & NETWORKING 16:05

REFRESHMENTS & NETWORKING

When: 16:05 - 16:35
REFRESHMENTS & NETWORKING 11:00

REFRESHMENTS & NETWORKING

When: 11:00 - 11:30
KEYNOTE USE CASE 1: AI in drug discovery 14:00

KEYNOTE USE CASE 1: AI in drug discovery

When: 14:00 - 14:20

Re-defining what it means to apply data driven healthcare for the development of novel medicines

USE CASE 2: AI in decision support 14:20

USE CASE 2: AI in decision support

When: 14:20 - 14:40
Using AI to tackle some of the everyday challenges experienced by the NHS – progress in reducing A&E waiting times
IN-CONVERSATION: Artificial Intelligence and the brain15:05
DR. HEATHER BERLIN | DR. ALAIN DAGHER | MAXINE MACKINTOSH

Neuroscientist & Assistant Professor of Psychiatry, Icahn School of Medicine

Mount Sinai

|

Neurologist and Professor, Montreal Neurological Institute

McGill University

|

Co-Founder

One HealthTech

DR. HEATHER BERLIN

Neuroscientist & Assistant Professor of Psychiatry, Icahn School of Medicine

Mount Sinai

DR. ALAIN DAGHER

Neurologist and Professor, Montreal Neurological Institute

McGill University

MAXINE MACKINTOSH

Co-Founder

One HealthTech

IN-CONVERSATION: Artificial Intelligence and the brain

When: 15:05 - 15:25
Keynote Use Case 615:45
CHRISTOPHER RUDOLF

Founder and CEO

Volv Global

CHRISTOPHER RUDOLF

Founder and CEO

Volv Global

Keynote Use Case 6

When: 15:45 - 16:05
USE CASE 3: AI in clinical trials14:40
JAQUIE FINN

Global Head of Digital Health

Cambridge Consultants

JAQUIE FINN

Global Head of Digital Health

Cambridge Consultants

USE CASE 3: AI in clinical trials

When: 14:40 - 15:00

How continuous patient monitoring can maximise the likelihood of clinical and commercial success

KEYNOTE TECH TALK 1: AI in prognosis Death and data science: how machine learning can improve end-of-life care 14:00

KEYNOTE TECH TALK 1: AI in prognosis Death and data science: how machine learning can improve end-of-life care

When: 14:00 - 14:20
TECH TALK 3: AI in decision support AutoPrognosis - automated clinical prognostic modelling in cystic fibrosis care via a bayesian optimisation with structured kernel 14:40

TECH TALK 3: AI in decision support AutoPrognosis - automated clinical prognostic modelling in cystic fibrosis care via a bayesian optimisation with structured kernel

When: 14:40 - 15:00
TECH TALK 5: AI in gene editing 15:25

TECH TALK 5: AI in gene editing

When: 15:25 - 15:45
Optimising CRISPR gene editing using machine learning technologies
TECH TALK 6: AI in assisted living Using AI and assistive robots to develop ‘smart home’ systems to support older adults in their own home 15:45

TECH TALK 6: AI in assisted living Using AI and assistive robots to develop ‘smart home’ systems to support older adults in their own home

When: 15:45 - 16:05
TECH TALK 2 14:20

TECH TALK 2

When: 14:20 - 14:40
STARTUP STORY 1: AI in clinical trials 14:00

STARTUP STORY 1: AI in clinical trials

When: 14:00 - 14:15
STARTUP STORY 2: AI in health and wellbeing - Medicus14:15
DR. BAHER AL HAKIM

CEO

Medicus

DR. BAHER AL HAKIM

CEO

Medicus

STARTUP STORY 2: AI in health and wellbeing - Medicus

When: 14:15 - 14:30
   
STARTUP STORY 3: AI in diagnosis 14:30

STARTUP STORY 3: AI in diagnosis

When: 14:30 - 14:45
     
STARTUP STORY 4: AI in product authentication and counterfeit protection - AlpVision14:45
DR. FRED JORDAN

CEO

AlpVision

DR. FRED JORDAN

CEO

AlpVision

STARTUP STORY 4: AI in product authentication and counterfeit protection - AlpVision

When: 14:45 - 15:00
STARTUP STORY 5: AI in post-surgery infection prediction – Healthplus.ai15:00
DR. BART GEERTS

Consultant Cardiac Anaesthetist and Founder

AMC and Healthplus.ai

DR. BART GEERTS

Consultant Cardiac Anaesthetist and Founder

AMC and Healthplus.ai

STARTUP STORY 5: AI in post-surgery infection prediction – Healthplus.ai

When: 15:00 - 15:15
STARTUP STORY 6: AI in personalized health - ExactCure15:15
DR. FREDERIC DAYAN

CEO

ExactCure

DR. FREDERIC DAYAN

CEO

ExactCure

STARTUP STORY 6: AI in personalized health - ExactCure

When: 15:15 - 15:30
STARTUP STORY 7: AI in decision support 15:30

STARTUP STORY 7: AI in decision support

When: 15:30 - 15:45
   
STARTUP STORY 8: AI to unlock digital capability - Unit815:45
DR. MARCIN PIETRZYK

CEO

Unit8

DR. MARCIN PIETRZYK

CEO

Unit8

STARTUP STORY 8: AI to unlock digital capability - Unit8

When: 15:45 - 16:00
WORKSHOP 1: The realities of day-to-day AI deployment in healthcare - how will the profession evolve as relevant technologies become more mainstream 14:00

WORKSHOP 1: The realities of day-to-day AI deployment in healthcare - how will the profession evolve as relevant technologies become more mainstream

When: 14:00 - 15:00
   
WORKSHOP 3: A clinicians guide to regulations in AI for healthcare 15:10

WORKSHOP 3: A clinicians guide to regulations in AI for healthcare

When: 15:10 - 16:10

MAIN STAGE

MAIN STAGE

REAL WORLD USE CASES

STREAM 1: Examining the potential to transform care delivery and life science research, challenges faced and lessons learnt

DEEP DIVE TECH TALKS

STREAM 2: Fundamental breakthroughs using AI which will change lives and reshape healthcare

STARTUPS SHOWCASE

STARTUPS SHOWCASE

CLINICIANS WORKSHOPS

STREAM 3: AI under the hood: Clinicians Workshops

AI WORKSHOPS

STREAM 4: AI under the hood - clinicians workshops

SPEAKER Q&A STAGE

SPEAKER Q&A STAGE
09:00 09:1509:3009:4510:0010:1510:3010:4511:0011:1511:3011:4512:0012:1512:3012:4513:0013:1513:3013:4514:0014:1514:3014:4515:0015:1515:3015:4516:0016:1516:3016:4517:0017:1517:30
WELCOME09:00
SARAH PORTER | BABITA SHARMA

CEO and Founder

Inspired Minds

|

Television Presenter

BBC

SARAH PORTER

CEO and Founder

Inspired Minds

BABITA SHARMA

Television Presenter

BBC

WELCOME

When: 09:00 - 09:20
IN-CONVERSATION: Where can big tech companies make the biggest impact on healthcare?09:20
DR. TOBY COSGROVE

Executive Advisor, Google Cloud

Executive Advisor and Former President & CEO, Cleveland Clinic

DR. TOBY COSGROVE

Executive Advisor, Google Cloud

Executive Advisor and Former President & CEO, Cleveland Clinic

IN-CONVERSATION: Where can big tech companies make the biggest impact on healthcare?

When: 09:20 - 09:45
     
HEADLINER: National scale impact - next generation analysis of health patterns using AI 09:45

HEADLINER: National scale impact - next generation analysis of health patterns using AI

When: 09:45 - 10:10
PANEL DISCUSSION: MINISTERS PERSPECTIVE Addressing social determinants for health using AI10:10
DR. ALEXANDER FINLAYSON

GP and Co-Founder, Nye, and Doll Fellow at Oxford University

DR. ALEXANDER FINLAYSON

GP and Co-Founder, Nye, and Doll Fellow at Oxford University

PANEL DISCUSSION: MINISTERS PERSPECTIVE Addressing social determinants for health using AI

When: 10:10 - 10:45

The social determinants of health are the economic and social conditions that influence individual and group differences in health status. They are the health promoting factors found in one's living and working conditions (such as the distribution of income, wealth, influence, and power), rather than individual risk factors (such as behavioural risk factors or genetics) that influence the risk for a disease, or vulnerability to disease or injury. The distributions of social determinants are often shaped by public policies. The World Health Organization says, "This unequal distribution of health-damaging experiences is not in any sense a 'natural' phenomenon but is the result of a toxic combination of poor social policies, unfair economic arrangements [where the already well-off and healthy become even richer and the poor who are already more likely to be become even poorer], and bad politics.’’

AI has the potential to improve health. Like all technologies it can do good and causes harm. States have a hugely important role in creating the enabling landscape. Some changes may sit outside the scope. 

  • What initiatives have been successful in maximising the potential good and minimising the potential harm of AI for citizen's health and what can other countries learn from these?
  • What initiatives are in place or are being put in place in the near future for this? What are your roadmaps to unlock the AI capabilities for healthcare?
  • Health is determined not just by healthcare but by how we shop, what we eat and how we move (the so-called social determinants of health). Should the state be enabling citizens and healthcare providers ready access to the data held by banks, online stores and the large global tech companies?
  • What changes sit outside the gift of an individual nation state e.g. opening up the data of global tech companies, monopolies, equality across the global system - and how might they be addressed?
  • What are you most worried about?
  • What are you most excited about?

Interviewer: Dr. Alexander Finlayson,GP and Co-Founder, Nye, and Doll Fellow, Oxford University

HEADLINER: The Phoenix Partnership 10:45

HEADLINER: The Phoenix Partnership

When: 10:45 - 11:10
CLOSING HEADLINER: Consumer empowerment – how Amazon provides better insight into medical data to help healthcare consumers make more informed health decisions 15:40

CLOSING HEADLINER: Consumer empowerment – how Amazon provides better insight into medical data to help healthcare consumers make more informed health decisions

When: 15:40 - 16:05
CLOSING PANEL DISCUSSION: Security, AI and rethinking design for patient experience - what will the next generation of medical devices be like?16:05
ROLAND ROTT

Global General Manager of Women´s Health Ultrasound, GE Healthcare

ROLAND ROTT

Global General Manager of Women´s Health Ultrasound, GE Healthcare

CLOSING PANEL DISCUSSION: Security, AI and rethinking design for patient experience - what will the next generation of medical devices be like?

When: 16:05 - 16:45
   
IN CONVERSATION: Amazon-Berkshire-JPMorgan Health Venture: evolving business models in healthcare for better outcome 16:45

IN CONVERSATION: Amazon-Berkshire-JPMorgan Health Venture: evolving business models in healthcare for better outcome

When: 16:45 - 17:05
CLOSING HEADLINER: How China’s biggest e-commerce company Alibaba is delivering smart health services, driven by the internet and AI 17:05

CLOSING HEADLINER: How China’s biggest e-commerce company Alibaba is delivering smart health services, driven by the internet and AI

When: 17:05 - 17:30
   
CLOSE OF INTELLIGENT HEALTH 17:30

CLOSE OF INTELLIGENT HEALTH

When: 17:30 - 17:30
LUNCH & NETWORKING 13:00

LUNCH & NETWORKING

When: 13:00 - 14:00
REFRESHMENTS & NETWORKING 11:10

REFRESHMENTS & NETWORKING

When: 11:10 - 11:40
REFRESHMENTS & NETWORKING 15:20

REFRESHMENTS & NETWORKING

When: 15:20 - 15:40
KEYNOTE USE CASE 7: AI in diagnostics Developing a tool that uses deep learning to analyse optical coherence tomography images and flag up those that are more likely to show significant pathology 14:00

KEYNOTE USE CASE 7: AI in diagnostics Developing a tool that uses deep learning to analyse optical coherence tomography images and flag up those that are more likely to show significant pathology

When: 14:00 - 14:20
USE CASE 10: AI in skin cancer diagnosis14:55
ERIK DE HEUS

CEO

SkinVision
ERIK DE HEUS

CEO

SkinVision

USE CASE 10: AI in skin cancer diagnosis

When: 14:55 - 15:10
TECH TALK 11: AI in robotics The future of robots in medicine 14:00

TECH TALK 11: AI in robotics The future of robots in medicine

When: 14:00 - 14:20
USE CASE 11: AI in patient education and training Where has large pharma struggled and what’s the next level?15:10
VIMAL NARAYANAN

Founder and CEO

Medtrix
VIMAL NARAYANAN

Founder and CEO

Medtrix

USE CASE 11: AI in patient education and training Where has large pharma struggled and what’s the next level?

When: 15:10 - 15:20
KEYNOTE: AI in healthcare in low-income communities12:40
DR. ANN AERTS

Head

Novartis Foundation

DR. ANN AERTS

Head

Novartis Foundation

KEYNOTE: AI in healthcare in low-income communities

When: 12:40 - 13:00
KEYNOTE: What the World Health Organization is doing with big data and artificial intelligence for achieving universal health coverage11:40
BABITA SHARMA

Television Presenter

BBC

BABITA SHARMA

Television Presenter

BBC

KEYNOTE: What the World Health Organization is doing with big data and artificial intelligence for achieving universal health coverage

When: 11:40 - 12:00
The latest in population level application of AI in healthcare and tracking progress made towards the health-related Sustainable Development Goals
PANEL DISCUSSION: Progress towards the standardization of a framework for the performance benchmarking of ‘AI for Health’ algorithms12:00
NAOMI LEE

Executive Editor – Digital

The Lancet

NAOMI LEE

Executive Editor – Digital

The Lancet

PANEL DISCUSSION: Progress towards the standardization of a framework for the performance benchmarking of ‘AI for Health’ algorithms

When: 12:00 - 12:40
KEYNOTE USE CASE 7: AI in diagnostics14:00
BABITA SHARMA

Television Presenter

BBC

BABITA SHARMA

Television Presenter

BBC

KEYNOTE USE CASE 7: AI in diagnostics

When: 14:00 - 14:20
Developing a tool that uses deep learning to analyse optical coherence tomography images and flag up those that are more likely to show significant pathology Examining the potential to transform care delivery and life science research, challenges faced and lessons learned
USE CASE 8: AI in AR/VR14:20
JENNIFER ESPOSITO

Vice President – Health at Magic Leap

JENNIFER ESPOSITO

Vice President – Health at Magic Leap

USE CASE 8: AI in AR/VR

When: 14:20 - 14:40
USE CASE 9: Recursion Pharma14:40
CHRIS GIBSON

Co-Founder and CEO at Recursion Pharma

CHRIS GIBSON

Co-Founder and CEO at Recursion Pharma

USE CASE 9: Recursion Pharma

When: 14:40 - 14:55
TECH TALK 11: AI in robotics The future of robots in medicine 14:00

TECH TALK 11: AI in robotics The future of robots in medicine

When: 14:00 - 14:20
TECH TALK 12 14:20

TECH TALK 12

When: 14:20 - 14:40
TECH TALK 13: AI in dermatology14:40
PROF. ALEXANDER NAVARINI | PROF. PETER SCHMID-GRENDELMEIER | DR. LIAM CAFFERY | DR. CHRISTOPHE HSU

Head of the Department of Dermatology

University of Basel

|

Head Allergy Unit, Dept. of Dermatology

University Hospital Zürich

|

Telehealth Technology Director

University of Queensland

|

Consultant in Teledermatology and AI

University Hospital of Basel

PROF. ALEXANDER NAVARINI

Head of the Department of Dermatology

University of Basel

PROF. PETER SCHMID-GRENDELMEIER

Head Allergy Unit, Dept. of Dermatology

University Hospital Zürich

DR. LIAM CAFFERY

Telehealth Technology Director

University of Queensland

DR. CHRISTOPHE HSU

Consultant in Teledermatology and AI

University Hospital of Basel

TECH TALK 13: AI in dermatology

When: 14:40 - 15:20
How can we use AI to make accurate diagnosis and be implemented in Tanzania
KEYNOTE TECH TALK 7: AI in mental health 11:40

KEYNOTE TECH TALK 7: AI in mental health

When: 11:40 - 12:00
Digital phenotypes - correlating keyboard use patterns to help identify measures of emotion, cognition, and behaviour. Fundamental breakthroughs using AI which will change lives and reshape healthcare
TECH TALK 8: AI in smart diagnostics 12:00

TECH TALK 8: AI in smart diagnostics

When: 12:00 - 12:20
Internet of Things and AI for real-time monitoring and analysis of the patient’s vital signs
TECH TALK 9: AI in genomics 12:20

TECH TALK 9: AI in genomics

When: 12:20 - 12:40
Health Nucleus - Integrating AI and genomics with mature medical diagnostic technologies to offer proactive, versus reactive health care
TECH TALK 10: 12:40

TECH TALK 10:

When: 12:40 - 13:00
STARTUPS SHOWCASE 14:00

STARTUPS SHOWCASE

When: 14:00 - 15:20
Five AI startups short-listed for our showcase get 10 minutes to pitch their business idea to five judges. After each pitch, judges get 5 minutes to ask questions about the venture.
START UP STORY 9: AI in process optimisation 11:40

START UP STORY 9: AI in process optimisation

When: 11:40 - 11:55
START UP STORY 10 11:55

START UP STORY 10

When: 11:55 - 12:10
START UP STORY 11: AI in patient engagement 12:10

START UP STORY 11: AI in patient engagement

When: 12:10 - 12:25
START UP STORY 12 12:25

START UP STORY 12

When: 12:25 - 12:40
START UP STORY 13: AI to combat global health epidemics 12:40

START UP STORY 13: AI to combat global health epidemics

When: 12:40 - 12:55
WORKSHOP 7: A roadmap for data driven thinking and AI adoption in hospitals 14:00

WORKSHOP 7: A roadmap for data driven thinking and AI adoption in hospitals

When: 14:00 - 15:20
A roadmap for data driven thinking and AI adoption in hospitals
  • CMIO
  • Startups
  • Clinician
  • Tech company
WORKSHOP 5: Problem meets solution 11:40

WORKSHOP 5: Problem meets solution

When: 11:40 - 13:00
This session is where clinicians can bring their datasets with them and can sound-out the problem they have to see if there are data scientists who are able to help them solve their challenges. For entrepreneurs with a shared passion to innovate healthcare by solving real-world problems  
WORKSHOP 8: You have the funding and you have the algorithm but how do you unlock the enabling technology infrastructure to gain compliance approval? 14:00

WORKSHOP 8: You have the funding and you have the algorithm but how do you unlock the enabling technology infrastructure to gain compliance approval?

When: 14:00 - 15:20
Examples of companies who have gotten over the compliance burden and can share how they deployed the infrastructure from the US, UK, Germany etc. and see what similarities and differences there were
WORKSHOP 6: Learn how to bring your ML models to production in a scalable way 11:40

WORKSHOP 6: Learn how to bring your ML models to production in a scalable way

When: 11:40 - 13:00

DON’T MISS A THING!

Subscribe to the IH mailing list to be the first to receive the latest news, articles and reports, speakers announcements, programme updates, ticket sales and much more…

SUBSCRIBE TO NEWSLETTER